On September 6, 2022, J. Patrick Nelli and Health Catalyst, Inc. (the Company) mutually agreed that, effective September 30, 2022, Mr. Nelli will transition from his position as President of the Company to Senior Advisor, in order to enable a smooth transition of his prior responsibilities as President. In connection with the foregoing, the Company and Mr. Nelli anticipate entering into a separation and release agreement when Mr. Nelli ceases to be employed by the Company. Mr. Nelli's transition is not the result of any disagreement or conflict with the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.805 USD | -0.51% | +1.65% | -27.00% |
May. 10 | Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating | MT |
May. 09 | Health Catalyst Seeks M&A | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.00% | 404M | |
-18.12% | 213B | |
-8.76% | 65.5B | |
-2.46% | 55.75B | |
-9.25% | 46.17B | |
-2.42% | 39.05B | |
-6.31% | 33.84B | |
-8.22% | 28.45B | |
+109.46% | 27.45B | |
+5.20% | 21.62B |
- Stock Market
- Equities
- HCAT Stock
- News Health Catalyst, Inc.
- Health Catalyst, Inc. Announces Executive Changes